Policy & Regulation
Initiator Pharma secures two European patents for pudafensine
19 August 2026 - Danish clinical-stage pharmaceutical company Initiator Pharma A/S (FN STO:INIT) announced on Wednesday that it has secured two new European patents for its lead drug candidate pudafen...
Resivant Medical reports first patient cases with Cutiva PLUS Skin Closure System
19 August 2026 - Resivant Medical announced on Tuesday the first patient uses of its Cutiva PLUS Skin Closure System, marking the first use of its proprietary Cutiva siliconised adhesive platform.This...
Andelyn Biosciences to develop and manufacture gene therapy AAV9-GM2 for Queen's University to treat GM2 gangliosidoses
19 August 2026 - Andelyn Biosciences Inc, a cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), announced on Tuesday that it has partnered with Queen's University to...
Piramal Pharma acquires controlling stake in Yapan Bio
19 August 2026 - Indian pharmaceutical company Piramal Pharma Ltd (PPL) (NSE:PPLPHARMA) (BSE:543635) announced on Tuesday that it has completed the acquisition of an incremental 40.67% stake in Yapan ...
Curavit acquires Lindus Health CRO assets
19 August 2026 - Curavit Clinical Research, a clinical research organisation (CRO) and Remote Clinical Site, announced on Tuesday that it has acquired the CRO assets of Lindus Health.This transaction ...
Hansa Biopharma reports first Australian transplant using Idefirix
18 August 2026 - Swedish immunomodulatory therapy company Hansa Biopharma AB (STO: HNSA) on Tuesday announced that the first commercial patient in Australia has received a living donor kidney transpla...